CYduct Diagnostics CYDX Stock
CYduct Diagnostics Price Chart
CYduct Diagnostics CYDX Financial and Trading Overview
| CYduct Diagnostics stock price | 0.4 USD |
| Previous Close | 0.4 USD |
| Open | 0.4 USD |
| Bid | 0.4 USD x 290000 |
| Ask | 1.5 USD x 100000 |
| Day's Range | 0.4 - 0.4 USD |
| 52 Week Range | 0.2 - 2.9 USD |
| Volume | 160 USD |
| Avg. Volume | 44 USD |
| Market Cap | 2.11M USD |
| Beta (5Y Monthly) | -0.776 |
| PE Ratio (TTM) | 0.52473956 |
| EPS (TTM) | 0.77 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CYDX Valuation Measures
| Enterprise Value | 282.63K USD |
| Trailing P/E | 0.52473956 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.1257806 |
| Price/Book (mrq) | 0.063484564 |
| Enterprise Value/Revenue | 0.82 |
| Enterprise Value/EBITDA | -0.563 |
Trading Information
CYduct Diagnostics Stock Price History
| Beta (5Y Monthly) | -0.776 |
| 52-Week Change | -19.076% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 2.9 USD |
| 52 Week Low | 0.2 USD |
| 50-Day Moving Average | 0.58 USD |
| 200-Day Moving Average | 0.56 USD |
CYDX Share Statistics
| Avg. Volume (3 month) | 44 USD |
| Avg. Daily Volume (10-Days) | 27 USD |
| Shares Outstanding | 5.24M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1:250 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2011 |
| Most Recent Quarter (mrq) | March 31, 2012 |
| Next Fiscal Year End | December 31, 2012 |
Profitability
| Profit Margin | 39.59% |
| Operating Margin (ttm) | -71.67% |
| Gross Margin | 60.93% |
| EBITDA Margin | -145.70% |
Management Effectiveness
| Return on Assets (ttm) | -13.60% |
| Return on Equity (ttm) | 8.39% |
Income Statement
| Revenue (ttm) | 344.78K USD |
| Revenue Per Share (ttm) | 1.94 USD |
| Quarterly Revenue Growth (yoy) | 20.10% |
| Gross Profit (ttm) | 210.11K USD |
| EBITDA | -502354 USD |
| Net Income Avi to Common (ttm) | 136.51K USD |
| Diluted EPS (ttm) | 0.768 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 13.33K USD |
| Total Cash Per Share (mrq) | 0.04 USD |
| Total Debt (mrq) | 171.98K USD |
| Total Debt/Equity (mrq) | 8.82 USD |
| Current Ratio (mrq) | 1.781 |
| Book Value Per Share (mrq) | 6.348 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -160772 USD |
| Levered Free Cash Flow (ttm) | -541365 USD |
Profile of CYduct Diagnostics
| Country | United States |
| State | CT |
| City | Westport |
| Address | 1698 Post Rd. E |
| ZIP | 06880 |
| Phone | 888-545-9112 |
| Website | https://cyductdx.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 3 |
CYduct Diagnostics, Inc., a healthcare company, develops, produces, and markets medical devices for the assessment, identification, diagnosis and treatment of breast cancer. The company offers HALO system, a noninvasive device that utilizes proprietary technology to obtain breast fluid; and MammoView, a fiberoptic technology with the ability to view and collect cells and other abnormalities. It also provides women and clinicians with technology that will lead the Intraductal approach to breast cancer and improvement in breast healthcare. The company was formerly known as Solos Endoscopy, Inc. and changed its name to CYduct Diagnostics, Inc. in December 2020. CYduct Diagnostics, Inc. was incorporated in 1986 and is based in Westport, Connecticut.
Q&A For CYduct Diagnostics Stock
What is a current CYDX stock price?
CYduct Diagnostics CYDX stock price today per share is 0.4 USD.
How to purchase CYduct Diagnostics stock?
You can buy CYDX shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CYduct Diagnostics?
The stock symbol or ticker of CYduct Diagnostics is CYDX.
Which industry does the CYduct Diagnostics company belong to?
The CYduct Diagnostics industry is Medical Devices.
How many shares does CYduct Diagnostics have in circulation?
The max supply of CYduct Diagnostics shares is 5.24M.
What is CYduct Diagnostics Price to Earnings Ratio (PE Ratio)?
CYduct Diagnostics PE Ratio is 0.52473956 now.
What was CYduct Diagnostics earnings per share over the trailing 12 months (TTM)?
CYduct Diagnostics EPS is 0.77 USD over the trailing 12 months.
Which sector does the CYduct Diagnostics company belong to?
The CYduct Diagnostics sector is Healthcare.